InsidersTradesSigma
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Explore the full record of transactions filed by ARCH Venture Partners IX, LLC. Officer active across 3 companies, notably Lyell Immunopharma, Inc.. In total, 18 disclosures have been published. The latest transaction was filed on 8 June 2022 — J. Regulator: SEC (Form 4). The full history is free.
Declarations18 total
0217,781 shares0
Common Stock
SEC:0001062993-22-014696:0·
0217,781 shares0
Common Stock
SEC:0001062993-22-014426:0·
0762,233 shares0
Common Stock
SEC:0001062993-21-013385·
0762,233 shares0
Common Stock
SEC:0001062993-21-013385:0·
0217,781 shares0
Common Stock
SEC:0001062993-21-011917·
0217,781 shares0
Common Stock
SEC:0001062993-21-011917:0·
0217,781 shares0
Common Stock
SEC:0001062993-21-011643·
0217,781 shares0
Common Stock
SEC:0001062993-21-011643:0·
01,742,248 shares0
Common Stock
SEC:0001062993-21-006362·
01,742,248 shares0
Common Stock
SEC:0001062993-21-006362:0·
0200,000 shares0
Common Stock
SEC:0001062993-21-006293·
0200,000 shares0
Common Stock
SEC:0001062993-21-006293:0·
0200,000 shares0
Common Stock
SEC:0001062993-21-006092·
0200,000 shares0
Common Stock
SEC:0001062993-21-006092:0·
0435,562 shares0
Common Stock
SEC:0001062993-21-005942·
0435,562 shares0
Common Stock
SEC:0001062993-21-005942:0·
18,206,358 shares
Common Stock
SEC:0000899243-21-025523·
18,206,358 shares
Common Stock
SEC:0000899243-21-025523:0·
18 of 18 declarations
About ARCH Venture Partners IX, LLC
ARCH Venture Partners IX, LLC is an investor in Lyell Immunopharma, Inc.
